<?xml version="1.0" encoding="UTF-8"?>
<p>TVEC showed strong lytic activity against various human tumors, including malignant melanoma. Melanoma patients treated with TVEC exhibited accumulation of CD8+ T-cells in injected lesions and decrease of CD4+ FoxP3+ regulatory cells as well as CD14+ myeloid-derived suppressor cells [
 <xref rid="B115-biomedicines-08-00060" ref-type="bibr">115</xref>]. Together, these findings demonstrate the effect of TVEC in the infection process and the driving of transgene expression in different cell types.
</p>
